Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/130896
Title: Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones
Authors: Aluru, R.
Mukherjee, A.
Zyryanov, G. V.
Majee, A.
Santra, S.
Issue Date: 2023
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Citation: Aluru, R, Mukherjee, A, Zyryanov, G, Majee, A & Santra, S 2023, 'Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones', Current Issues in Molecular Biology, Том. 45, № 10, стр. 8461-8475. https://doi.org/10.3390/cimb45100533
Aluru, R., Mukherjee, A., Zyryanov, G., Majee, A., & Santra, S. (2023). Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones. Current Issues in Molecular Biology, 45(10), 8461-8475. https://doi.org/10.3390/cimb45100533
Abstract: Natural products are a boundless source for the development of pharmaceutical agents against a wide range of human diseases. Accordingly, naturally occurring aurones possess various biological benefits, such as anticancer, antioxidant, antimicrobial, antidiabetic, anti-inflammatory, antiviral and neuroprotective effects. In addition, various studies have revealed that aurones are potential templates for the regulation of diabetes mellitus and its associated complications. Likewise, certain aurones and their analogues have been found to be remarkable kinase inhibitors of DARK2, PPAR-γ, PTPM1, AGE, α-amylase and α-glucosidase, which represents a promising approach for the treatment of chronic metabolic disorders such as diabetes. Therefore, in our present study, we provide a detailed account of the advances in aurones as antidiabetic agents over the past decade. © 2023 by the authors.
Keywords: ANTIDIABETIC
AURONES
CHALCONE
FLAVONOIDS
Α-GLUCOSIDASE INHIBITOR
AMYLASE
ANTIDIABETIC AGENT
AURONE
CHALCONE DERIVATIVE
ETHYLENE OXIDE DERIVATIVE
FLAVANOID
FLAVONE DERIVATIVE
GLUCOSIDASE
NATURAL PRODUCT
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA
UNCLASSIFIED DRUG
ANNULATION REACTION
ANTIDIABETIC ACTIVITY
ANTIINFLAMMATORY ACTIVITY
ANTIMICROBIAL ACTIVITY
ANTINEOPLASTIC ACTIVITY
ANTIOXIDANT ACTIVITY
ANTIVIRAL ACTIVITY
BIOLOGICAL ACTIVITY
BIOSYNTHESIS
CYCLIZATION
DIABETES MELLITUS
DRUG DEVELOPMENT
DRUG SYNTHESIS
GLUCOSE ABSORPTION
GLUCOSE METABOLISM
HUMAN
HYPERGLYCEMIA
IC50
METABOLIC DISORDER
NEUROPROTECTION
REVIEW
SIGNAL TRANSDUCTION
URI: http://elar.urfu.ru/handle/10995/130896
Access: info:eu-repo/semantics/openAccess
cc-by
License text: https://creativecommons.org/licenses/by/4.0/
SCOPUS ID: 85175087801
WOS ID: 001098241800001
PURE ID: 47647488
ISSN: 1467-3037
DOI: 10.3390/cimb45100533
metadata.dc.description.sponsorship: Ministry of Education and Science of the Russian Federation, Minobrnauka
This research was funded by the Ministry of Science and Higher Education of the Russian Federation (Ural Federal University Program of Development within the Priority-2030 Program).
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85175087801.pdf4,48 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons